These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31776408)

  • 1. Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study.
    Pérez-Hernández C; Blasco A; Gándara Á; Mañas A; Rodríguez-López MJ; Martínez V; Fernandez-Nistal A; Montoto C
    Sci Rep; 2019 Nov; 9(1):17701. PubMed ID: 31776408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer.
    Hjermstad MJ; Kaasa S; Caraceni A; Loge JH; Pedersen T; Haugen DF; Aass N;
    BMJ Support Palliat Care; 2016 Sep; 6(3):344-52. PubMed ID: 27342412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes.
    Narayana A; Katz N; Shillington AC; Stephenson JJ; Harshaw Q; Frye CB; Portenoy RK
    Pain; 2015 Feb; 156(2):252-259. PubMed ID: 25599446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
    Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
    Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
    [No Abstract]   [Full Text] [Related]  

  • 5. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients.
    Samolsky Dekel BG; Remondini F; Gori A; Vasarri A; Di Nino G; Melotti RM
    Clin Neurol Neurosurg; 2016 Feb; 141():23-9. PubMed ID: 26731461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.
    Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A
    Eur J Pain; 2015 Aug; 19(7):881-8. PubMed ID: 25370838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced
    Fan R; Li X; Yang S; Bu X; Chen Y; Wang Y; Qiu C
    Pain Res Manag; 2022; 2022():8943292. PubMed ID: 35463627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
    Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
    Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study.
    Rodríguez MJ; de la Torre R; Ortega JL; Trinidad JM; Benítez D; Jiménez AJ; Sanz-Yagüe A; Soler B; Torres LM
    Curr Med Res Opin; 2018 Apr; 34(4):701-709. PubMed ID: 28914555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study.
    Gatti A; Gentili M; Baciarello M; Lazzari M; Marzi R; Palombo E; Sabato AF; Fanelli G
    Pain Res Manag; 2014; 19(6):e168-71. PubMed ID: 24945289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
    Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
    BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):109-16. PubMed ID: 20481175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic.
    Raj SX; Thronaes M; Brunelli C; Hjermstad MJ; Klepstad P; Kaasa S
    Support Care Cancer; 2014 Jul; 22(7):1965-71. PubMed ID: 24595408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart.
    Thronæs M; Raj SX; Brunelli C; Almberg SS; Vagnildhaug OM; Bruheim S; Helgheim B; Kaasa S; Knudsen AK
    Support Care Cancer; 2016 Jun; 24(6):2565-74. PubMed ID: 26712631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Characterization of Breakthrough Pain Associated with Chronic Low Back Pain in the South of Spain: A Cross-Sectional, Multicenter, Observational Study.
    Torres LM; Jiménez AJ; Cabezón A; Rodríguez MJ
    Pain Res Treat; 2018; 2018():4325271. PubMed ID: 29850241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
    Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ
    Clin Drug Investig; 2015 Dec; 35(12):815-22. PubMed ID: 26507617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.
    Hernanz de Lucas R; Nuñez Fernández M; Gómez-Caamaño A; Morera López R; Fortes de la Torre I; de la Torre Tomás A; Muñoz-Garzón V; López Bermudo C; Mañas Rueda A
    Future Oncol; 2021 Mar; 17(8):943-954. PubMed ID: 33289432
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond the traditional definition of breakthrough pain: an observational study.
    Gatti A; Gentili M; Iorno V; Mammucari M; Tufaro G; Lazzari M; Sabato AF
    Adv Ther; 2013 Mar; 30(3):298-305. PubMed ID: 23444055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.